Recruiting

Risperidone & Olanzapine

Sponsor:

National Center for Research Resources (NCRR)

Code:

NCT00006195

Conditions

Schizophrenia

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Accepted

Interventions

risperidone

olanzapine

Study Details

Brief summary:

The overall purpose of this research is to look at how two of the most commonly prescribed newer antipsychotic medications, risperidone and olanzapine, affect substances in the body such as glucose and insulin. Undesirable changes in blood sugar control, or glucose regulation, and type 2 diabetes can occur more commonly in individuals with schizophrenia compared to healthy subjects and subjects with other psychiatric conditions. While abnormalities in glucose regulation were first reported in schizophrenia before the introduction of antipsychotic medications, antipsychotic treatment may contribute significantly to abnormalities in glucose regulation. Attention to the way that antipsychotic medications may affect glucose regulation has increased as doctors have become more concerned in general about disease- and drug-related medical complications, including weight gain during antipsychotic treatment.

Conditions

Schizophrenia

Study ID

NCT00006195

Status verified date

Dec, 2003

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Accepted

Inclusion Criteria:

  • meet DSM-IV criteria for schizophrenia, any type, or schizoaffective disorder;
  • able to give informed consent;
  • no medication changes for 2 weeks prior to and during the period of study;
  • currently taking olanzapine, risperidone, haloperidol or another typical antipsychotic

Study Design

Primary purpose

Treatment

Interventions and Outcome Measures

Interventions

risperidone

olanzapine

Central Contacts and Locations

Central contacts

Locations

Washington University

Recruiting

St. Louis, Missouri, United States, 63110

More Information

Sponsor

National Center for Research Resources (NCRR)

Last update posted

Oct 12, 2006

Last verified

Dec, 2003

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by National Center for Research Resources (NCRR) on 2006-10-12.